Do you want to read an article? Please log in or register.
Reducing the Clinical and Public Health Burden of Familial Hypercholesterolemia: A Global Call to Action
Heart, Artery and Coronary Diseases
COMMENTED
Related content
Cardiovascular Risk and DiseasesHeart, Artery and Coronary DiseasesLipid-Lowering Drugs
Statins for children with familial hypercholesterolemia
Cochrane Database Syst Rev.
Vuorio A, Kuoppala J, Kovanen PT, Humphries SE, Tonstad S, Wiegman A, Drogari E, Ramaswami U
doi: 10.1002/14651858.
RECOMMENDED
Cardiovascular Risk and Diseases
Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
★ 3
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
Lancet
EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC).
doi: 10.1016/S0140-6736(21)01122-3
Heart, Artery and Coronary Diseases
Global, regional, and national burden of congenital heart disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Lancet Child Adolesc Health.
GBD 2017 Congenital Heart Disease Collaborators
doi: 10.1016/S2352-4642(19)30402-X.
Cardiac Arrest or Death
Association of Public Health Initiatives With Outcomes for Out-of-Hospital Cardiac Arrest at Home and in Public Locations
JAMA Cardiol.
Fordyce CB, Hansen CM, Kragholm K, Dupre ME, Jollis JG, Roettig ML, Becker LB, Hansen SM, Hinohara TT, Corbett CC, Monk L, Nelson RD, Pearson DA, Tyson C, van Diepen S, Anderson ML, McNally B, Granger CB
doi: 10.1001/
Heart, Artery and Coronary DiseasesLipid-Lowering Drugs
Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children with Heterozygous Familial Hypercholesterolemia: The CHARON Study
Circulation.
Braamskamp MJAM, Langslet G, McCrindle BW, Cassiman DM, Francis GA, Gagne C, Gaudet D, Morrison KM, Wiegman A, Turner T, Miller E, Kusters DM, Raichlen JS, Martin PD, Stein EA, Kastelein JJP, Hutten BA
doi: 10.1161/CIRCULATIONAHA.
Cardiovascular Risk and Diseases
World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions
Lancet Glob Health.
WHO CVD Risk Chart Working Group.
doi: 10.1016/S2214-109X(19)30318-3.
Cardiac Arrest or Death
Global, regional, and national mortality among young people aged 10-24 years, 1950-2019: a systematic analysis for the Global Burden of Disease Study 2019
Lancet
GBD 2019 Adolescent Mortality Collaborators.
doi: 10.1016/S0140-6736(21)01546-4
Heart Failure
Empagliflozin and health-related quality of life outcomes in patients with heart failure with reduced ejection fraction: the EMPEROR-Reduced trial
Eur Heart J
Butler J, Anker SD, Filippatos G, Khan MS, Ferreira JP, Pocock SJ, Giannetti N, Januzzi JL, Piña IL, Lam CSP, Ponikowski P, Sattar N, Verma S, Brueckmann M, Jamal W, Vedin O, Peil B, Zeller C, Zannad F, Packer M, EMPEROR-Reduced Trial Committees and Investigators.
doi: 10.1093/eurheartj/ehaa1007
RECOMMENDED
Lipid-Lowering Drugs
Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia
★ 3
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
N Engl J Med.
Raal FJ, Kallend D, Ray KK, Turner T, Koenig W, Wright RS, Wijngaard PLJ, Curcio D, Jaros MJ, Leiter LA, Kastelein JJP, ORION-9 Investigators.
doi: 10.1056/NEJMoa1913805.